LAPTM5 (lysosomal protein transmembrane 5)

2012-11-01  

Identity

HGNC
LOCATION
1p35.2
LOCUSID
ALIAS
CLAST6
FUSION GENES

Other Information

Locus ID:

NCBI: 7805
MIM: 601476
HGNC: 29612
Ensembl: ENSG00000162511

Variants:

dbSNP: 7805
ClinVar: 7805
TCGA: ENSG00000162511
COSMIC: LAPTM5

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000162511ENST00000294507Q13571
ENSG00000162511ENST00000294507Q5TBB8

Expression (GTEx)

0
500
1000
1500

Pathways

PathwaySourceExternal ID
LysosomeKEGGko04142
LysosomeKEGGhsa04142

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
380188742024ZKSCAN5 activates LAPTM5 expression by recruiting SETD7 to promote metastasis in pancreatic ductal adenocarcinoma.0
380188742024ZKSCAN5 activates LAPTM5 expression by recruiting SETD7 to promote metastasis in pancreatic ductal adenocarcinoma.0
360373002023Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma.14
367991862023LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway.2
360373002023Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma.14
367991862023LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway.2
350914682022LCDR regulates the integrity of lysosomal membrane by hnRNP K-stabilized LAPTM5 transcript and promotes cell survival.15
351576092022Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy.9
352256542022LAPTM5 Restricts HIV-1 Infection in Dendritic Cells and Is Counteracted by Vpr.3
352940392022Spine‑specific downregulation of LAPTM5 expression promotes the progression and spinal metastasis of estrogen receptor‑positive breast cancer by activating glutamine‑dependent mTOR signaling.5
358424432022Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation.7
360373652022LAPTM5 mediates immature B cell apoptosis and B cell tolerance by regulating the WWP2-PTEN-AKT pathway.4
350914682022LCDR regulates the integrity of lysosomal membrane by hnRNP K-stabilized LAPTM5 transcript and promotes cell survival.15
351576092022Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy.9
352256542022LAPTM5 Restricts HIV-1 Infection in Dendritic Cells and Is Counteracted by Vpr.3

Citation

Dessen P

LAPTM5 (lysosomal protein transmembrane 5)

Atlas Genet Cytogenet Oncol Haematol. 2012-11-01

Online version: http://atlasgeneticsoncology.org/gene/53018/gene-fusions/cancer-prone-explorer/case-report-explorer/